|
|
|
市場調查報告書
全球的個人化醫療市場（2010∼2015年）：市場區塊別技術、機會、課題、將來預測
Personalized Medicine Market Worldwide (2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast
|
全球的個人化醫療市場（2010∼2015年）：市場區塊別技術、機會、課題、將來預測 是由出版商Renub Research在2011年02月所出版的。
這份英文市場調查報告書包含60 Pages 價格從美金1100起跳。
全球的個人化醫療市場以年間11.56％擴大，預期至2015年前將達1,484億美元。特別是透過基因體學和蛋白質體學領域的廣泛研究，期待過去無法治療的疾病上的治療效果，故此2個領域的成長最快速。
本報告，分析全球的個人化醫療市場，彙整市場區塊別的市場動向與將來預測、各種技術發展動向等，並加入參與企業的檔案資料，由下列摘要形式闡述。
第1章 報告摘要
第2章 個人化醫療的時代：新興產品
第3章 個人化醫療商業環境
第4章 全球：個人化醫療、將來預測、市佔率
- 個人化醫療與市場預測（2006∼2015年）
- 市場區塊別預測
- 技術別預測
第5章 市場區塊別個人化醫療市場（2006∼2015年）
- 基因改造產品
- 保健・疾病管理
- 消費者自我診斷市場
- 其他分子診斷市場以及將來預測
- 蛋白質體學以及基因體學市場以及將來預測
第6章 全球（技術）的個人化醫療市場與將來預測（2005∼2015年）
- 分子診斷
- 藥理基因體學
- SNP基因型
- 基因藥理學
- 藥理蛋白質體學
- 生物晶片
- 重點照護
- 基因篩檢
第7章 個人化醫療市場的成長促進因子
第8章 課題
第9章 合併・收購
第10章 主要企業
圖表
Abstract
Renub Research report titled “Personalized Medicine Market Worldwide
(2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future
Forecast” analysis the global personalized medicine. This research
report provides the global personalized medicine sector perspective from past
trends to future scenario (2006 to 2015). Personalized medicine segments like
Genetically Modified (GM) Products, Wellness & Disease Management, Targeted
Biologics, Other Molecular Diagnostics, Genomics and Proteomics and Consumer
Self Diagnostic markets data from 2006 to 2015 has been analyzed in this
report. From technology point of view segments like Molecular Diagnostics,
Biochips, Pharmacogenomics, SNP Genotyping, Pharmacogenetics, Point of Care
Testing, Genetic Screening and Pharmacoproteomics markets data from (2007 to
2014) has been provided in the report. Report reviews the competitive dynamic
of mergers and acquisitions in the personalized medicine market. The report
also provides valuable insight on the growth driver within the global
personalized medicine market and challenges faced in the global personalized
medicine market.
Personalized Medicine Market Overview
Personalized Medicine is often defined as “the right treatment for the
right person at the right time.” While the market for diagnostic tests
and therapies that leverage this new science is growing, the biggest
opportunities exist outside of the traditional healthcare sector. The
Personalized Medicine market is projected to grow 11.56 percent annually and
expected to reach US$ 148.4 Billion by 2015. The fastest growth is expected to
come from proteomics & genomics segment as extensive research in genomics and
proteomics is promising cures for disease which were previously untreatable.
Drug discovery companies are also likely to have ample opportunities to
slightly modify the lead compound in order to screen and exclude patients of a
certain genotype who are more prone to developing certain side effects from
clinical trials. Targeted Biologics is one of the most exciting areas of
therapeutic medicine and may represent about one in every four newly
commercialized drugs in the future. Targeted Biologics is the largest segment
in the personalized medicine market and forecasted to grow steadily with the
compound annual growth rate of 10 percent annually. Targeted Biologics gives
immense hope for the companies to cope up with the challenges in the
Personalized Medicine Market.
By the prolific segmentation of the market, this market has shown bigger
platform for the player who is in the category for the development of
personalized medicine. The pharmacogenomics and pharmacogenetics have had
provided exceptionally highly demonstrated platform for the personalized
medicine to ignite the substantial growth in the personalized medicine
diagnostic product by technology. Affymetrix Inc, HistoRx, Qiagen, Illumina
Inc, Hologic Inc are the key players in the personalized medicine market.
However, their leadership is likely to be challenged by the emergence of a new
breed of players who is working in this segment.
Research Highlights
- Proteomics & Genomics market is expected to be over US$ 30 Billion by 2015.
- Targeted Biologics is the largest segment in the personalized medicine
market and it is growing steadily with the compound annual growth rate of 10
percent.
- Targeted Biologics and Proteomics & Genomics together controls 57% of
market share in 2010
- Point of care diagnostics market share is expected to reduce to 36% from
42% in 2010
- Molecular Diagnostics is expected to have the second highest market share
after point of care diagnostics
Key Company Profiles
This section provides business overview and key financial information of the
companies listed below: Affymetrix Inc., HistoRx, Qiagen, Illumina, Inc, Third
Wave Technologies, Inc, Hologic, Inc.
Data Sources
Information and data in this report has been collected from various printable
and non-printable sources like Trade Journals, White papers, Online paid
databases, News websites, Government Agencies, Magazines, Newspapers and Trade
associations.
Table of Contents
1. Executive Summary
2. Era of Personalized Medicine: Emerging Products
- 2.1 Personalized Medicine: The New Science
- 2.2 The Promise of Personalized Medicine
3. The Personalized Medicine Business Landscape
- 3.1 A Complex Ecosystem of Companies
- 3.1.1 Therapeutics
- 3.1.2 Diagnostics
- 3.1.3 Theranostics (Companion Medicine)
4. Worldwide - Personalized Medicine Market, Future Forecast & Market Share
- 4.1 Worldwide - Personalized Medicine Market & Future Forecast (2006 -
2015)
- 4.2 By Segments - Personalized Medicine Market Share & Future Forecast
Worldwide (2006 - 2015)
- 4.3 By Technology - Personalized Medicine Diagnostic Market Share & Future
Forecast Worldwide (2007 - 2014)
5. By Segment - Personalized Medicine Market (from 2006 to 2015)
- 5.1 Genetically Modified (GM) Products Market & Future Forecast
- 5.2 Wellness & Disease Management Market & Future Forecast
- 5.3 Consumer Self-Diagnostic Market & Future Forecast
- 5.4 Other Molecular Diagnostics Market & Future Forecast
- 5.5 Proteomics & Genomics Market & Future Forecast
- 5.6 Targeted Biologics Market & Future Forecast
6. Worldwide (By Technology) - Personalized Medicine Diagnostic Product Market & Future Forecast (from 2005 to 2015)
- 6.1 Molecular Diagnostics Market & Future Forecast
- 6.2 Pharmacogenomics Market & Future Forecast
- 6.3 SNP Genotyping Market & Future Forecast
- 6.4 Pharmacogenetics Market & Future Forecast
- 6.5 Pharmacoproteomics Market & Future Forecast
- 6.6 Biochips Market & Future Forecast
- 6.7 Point of Care Testing Market & Future Forecast
- 6.8 Genetic Screening Market & Future Forecast
7. Key Drivers (Opportunities) of Growth in Personalized Medicine Market
- 7.1 Government Agencies Shaping Personalized Medicine
- 7.2 Organizations will Profit Together, Not Alone in the Personalized
Medicine
- 7.3 The Blockbuster Model of One Drug Fits all is under Pressure
8. Challenges
- 8.1 Reimbursement Policy & Regulatory Framework
- 8.2 Payers Worry That Cost of Personalized Medicine Could Be Unsustainable
- 9. Merger & Acquisition
10. Key Players
- 10.1 Affymetrix Inc.
- 10.2 Qiagen
- 10.3 Illumina Inc.
- 10.4 Hologic Inc
List of Figures:
- Figure 4 1: Worldwide - Personalized Medicine Market (Billion US$) 2006 -
2010
- Figure 4 2: Worldwide - Future Forecast for Personalized Medicine Market
(Billion US$) 2011 - 2015
- Figure 4 3: Worldwide - Segments of Personalized Medicine Market Share
(Percent), 2006 - 2010
- Figure 4 4: Worldwide - Future Forecast for Segments of Personalized
Medicine Market Share (Percent), 2011 - 2015
- Figure 4 5: Worldwide - Personalized Medicine Diagnostic Product Market
Share (Percent), 2007 - 2010
- Figure 4 6: Worldwide - Future Forecast for Personalized Medicine
Diagnostic Product Market Share (Percent), 2011 - 2014
- Figure 5 1: Worldwide - Personalized GM Products Market (Billion US$) 2006
- 2010
- Figure 5 2: Worldwide - Future Forecast for Personalized GM Products
Market (Billion US$) 2011 - 2015
- Figure 5 3: Worldwide - Personalized Wellness & Disease Management Market
(Billion US$) 2006 - 2010
- Figure 5 4: Worldwide - Future Forecast for Personalized Wellness &
Disease Management Market (Billion US$) 2011 - 2015
- Figure 5 5: Worldwide - Personalized Consumer Self-Diagnostic Market
(Billion US$) 2006 - 2010
- Figure 5 6: Worldwide - Future Forecast for Personalized Consumer
Self-Diagnostic Market (Billion US$) 2011 - 2015
- Figure 5 7: Worldwide - Other Molecular Diagnostics Market (Billion US$)
2006 - 2010
- Figure 5 8: Worldwide - Future Forecast for Other Molecular Diagnostics
Market (Billion US$) 2011 - 2015
- Figure 5 9: Worldwide - Personalized Medicine Proteomics & Genomics Market
(Billion US$) 2006 - 2010
- Figure 5 10: Worldwide - Future Forecast for Personalized Medicine
Proteomics & Genomics Market (Billion US$) 2011 - 2015
- Figure 5 11: Worldwide - Targeted Biologics Market (Billion US$) 2006 -
2010
- Figure 5 12: Worldwide - Future Forecast for Targeted Biologics Market
(Billion US$) 2011 - 2015
- Figure 6 1: Worldwide - Molecular Diagnostics Market (Billion US$), 2007 -
2009
- Figure 6 2: Worldwide - Future Forecast for Molecular Diagnostics Market
(Billion US$), 2010 - 2014
- Figure 6 3: United States - Molecular Diagnostics Market (Million US$),
2002 - 2010
- Figure 6 4: United States - Future Forecast for Molecular Diagnostics
Market (Million US$), 2010 - 2014
- Figure 6 5: Worldwide - Pharmacogenomics Market (Billion US$), 2005 - 2010
- Figure 6 6: Worldwide - Future Forecast for Pharmacogenomics Market
(Billion US$), 2011 - 2015
- Figure 6 7: Worldwide - SNP Genotyping Market (Billion US$), 2005 - 2010
- Figure 6 8: Worldwide - Future Forecast for SNP Genotyping Market (Billion
US$), 2011 - 2015
- Figure 6 9: Worldwide - Pharmacogenetics Market (Billion US$), 2005 - 2010
- Figure 6 10: Worldwide - Future Forecast for Pharmacogenetics Market
(Billion US$), 2011 - 2015
- Figure 6 11: Worldwide - Pharmacoproteomics Market (Billion US$), 2005 -
2010
- Figure 6 12: Worldwide - Future Forecast for Pharmacoproteomics Market
(Billion US$), 2011 - 2015
- Figure 6 13: Worldwide - Biochips Market (Billion US$), 2005 - 2010
- Figure 6 14: Worldwide - Future Forecast for Biochips Market (Billion
US$), 2011 - 2015
- Figure 6 15: Worldwide - Point of Care Testing Market (Billion US$), 2003,
2006 - 2010
- Figure 6 16: Worldwide - Future Forecast for Point of Care Testing Market
(Billion US$), 2011 - 2014
- Figure 6 17: Worldwide - Genetic Screening Market (Billion US$), 2005 -
2010
- Figure 6 18: Worldwide - Future Forecast for Genetic Screening Market
(Billion US$), 2011 - 2015
List of Tables:
- Table 9 1: Worldwide - Merger & Acquisition in Personalized Medicine
(Billion US$), 2007
- Table 9 2: Worldwide - M&A Deals in the IVD Sector with a Personalised
Medicine Theme (Million, US$), 2009
- Table 10 1: Affymetrix - Financials (Million US$) 2007 - 2009
- Table 10 2: Qiagen - Financials (Million US$) 2007 - 2009
- Table 10 3: Illumina Inc - Financial (Million US$) 2007 - 2009
- Table 10 4: Hologic Inc - Financials (Million US$) 2007 - 2009
預計個別化醫療市場於2015年時將達到1,484億美元
2011年03月11日
Global Information, Inc.已開始銷售印度市場調查公司Renub Research所發行的報告書「Personalized Medicine Market Worldwide (2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast (全球的個人化醫療市場（2010∼2015年）：市場區塊別技術、機會、課題、將來預測)」。
個別化醫療市場以年間11.56％的成長率推移，預測2015年時將達到總計1,484億美元。依據產業分析者的預測，從迄今原本不可能治療的疾病現在可期待治療的情形，可知最快速成長的部門為蛋白質體學與染色體組的區塊。兩者的市場被預測2015年時將達到超過300億美元的市場規模。
Renub Research的新報告針對個別化醫療部門，提供包含過去動向與未來發展的全球化分析，亦驗證M&A等市場的競爭力學。且敘述有關牽引該市場成長因素的重要洞察，此外，亦驗證有關全球個別化醫療市場所面臨的課題。
主要調查結果：
- 標的生物製劑是個別化醫療市場最大的市場區塊，以CAGR 10％平穩地推移。
- 2010年，標的生物製劑、蛋白質體學、染色體組的區塊獲得總市場57％的市佔率。
- 分子診斷僅次於定點照護檢驗診斷，被預測將獲得第2位市佔率。
- 預測定點照護檢驗診斷的市佔率2010年將從42％減少為36％。
本書區分被驗證之個別化醫療：
- 基因改造(GM)產品
- 健康&疾病管理
- 標的生物製劑
- 其他的分子診斷
- 染色體組與蛋白質體學
- 消費者自行診斷的市場
來自技術面的驗證區分：
- 分子診断
- 生物晶片
- 生染色體組藥理學
- SNP基因定型(SNP Genotyping)
- 藥理遺傳學
- 定點照護檢驗(point-of-care)
- 遺傳篩查
- Pharmacoproteomic
|
 |
